Shares of Nu Skin (NUS) were under pressure recently because the company’s Chinese operations were (rightfully) being questioned by Chinese regulators. Now a fine has been levied and NUS is set to rise again.
I am updating my spreadsheets and will have a complete research report out shortly, but need to place buy orders now for the Growth Portfolio and Aggressive Growth Portfolio. Check back later today for a complete analysis.